Literature DB >> 14696102

A comparison of reproductive risk factors for CIS lesions and invasive breast cancer.

Jan Wohlfahrt1, Fritz Rank, Niels Kroman, Mads Melbye.   

Abstract

A differential effect of reproductive factors on the incidence of carcinoma in situ of the breast (CIS) and invasive cancer may indicate that hormonal factors related to reproductive history not only influence the initial steps towards breast cancer but also preinvasive malignant lesions. A comparison of reproductive factors was performed using a population-based cohort of 1.5 million Danish women born between 1935 and 1978. Between 1983 and 1998, 15,590 cases of invasive breast cancer and 871 cases of CIS were identified using a database with extensive clinical information. Number of births and age at first birth were similarly associated with the risk of being diagnosed with ductal carcinoma in situ (DCIS) compared to invasive breast cancer [RR(DCIS)(per birth)/RR(invasive)(per birth) = 1.03(0.93-1.14), RR(DCIS)(per 5yr) /RR(invasive)(per 5yr) = 1.06(0.96-1.17)]. Also, the short-term risk the first 10 years after birth was similar for DCIS and invasive cancer [RR(DCIS) /RR(invasive) = 0.90 (0.74-1.09)]. Additional analyses were performed according to characteristics of the DCIS lesion (size, malignancy grade, noncomedo or comedo type). In conclusion, our observations do not support the theory that reproductive history is associated with progression from noninvasive to invasive breast cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14696102     DOI: 10.1002/ijc.11588

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Postmenopausal hormone therapy and ductal carcinoma in situ: a population-based case-control study.

Authors:  Lisa Calvocoressi; Meredith H Stowe; Darryl Carter; Elizabeth B Claus
Journal:  Cancer Epidemiol       Date:  2012-02-06       Impact factor: 2.984

Review 2.  Epidemiology of ductal carcinoma in situ.

Authors:  Karla Kerlikowske
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 3.  Ductal carcinoma in situ: risk factors and impact of screening.

Authors:  Beth A Virnig; Shi-Yi Wang; Tatyana Shamilyan; Robert L Kane; Todd M Tuttle
Journal:  J Natl Cancer Inst Monogr       Date:  2010

4.  Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.

Authors:  Lynette S Phillips; Robert C Millikan; Jane C Schroeder; Jill S Barnholtz-Sloan; Beverly J Levine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

5.  Risk factors for young-onset invasive and in situ breast cancer.

Authors:  Katie M O'Brien; Jenny Sun; Dale P Sandler; Lisa A DeRoo; Clarice R Weinberg
Journal:  Cancer Causes Control       Date:  2015-09-25       Impact factor: 2.506

6.  Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Authors:  G Farshid; T Sullivan; P Downey; P G Gill; S Pieterse
Journal:  Br J Cancer       Date:  2011-11-03       Impact factor: 7.640

7.  Ductal carcinoma in situ of the breast: a surgical perspective.

Authors:  Mohammed Badruddoja
Journal:  Int J Surg Oncol       Date:  2012-09-04

8.  Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lynn Rosenberg; Elisa V Bandera; Thaer Khoury; Melissa A Troester; Christine B Ambrosone; Julie R Palmer
Journal:  Breast       Date:  2019-11-06       Impact factor: 4.380

9.  A Randomized Trial of Calcium Plus Vitamin D Supplementation and Risk of Ductal Carcinoma In Situ of the Breast.

Authors:  Rita Peila; Xiaonan Xue; Jane A Cauley; Rowan Chlebowski; JoAnn E Manson; Rami Nassir; Nazmus Saquib; Aladdin H Shadyab; Zhenzhen Zhang; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  JNCI Cancer Spectr       Date:  2021-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.